These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10967445)

  • 41. Preparation and evaluation of metoprolol tartrate sustained-release pellets using hot melt extrusion combined with hot melt coating.
    Yang Y; Shen L; Li J; Shan WG
    Drug Dev Ind Pharm; 2017 Jun; 43(6):939-946. PubMed ID: 28128647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the coat quality of sustained release pellets by individual pellet dissolution methodology.
    Xu M; Liew CV; Heng PWS
    Int J Pharm; 2015 Jan; 478(1):318-327. PubMed ID: 25435182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Controlled release of pseudoephedrine HCl from pellets].
    Vertommen J
    Verh K Acad Geneeskd Belg; 1997; 59(6):451-88. PubMed ID: 9543819
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro evaluation of a sustained-release veterinary peroral pellet preparation.
    Ritschel WA; Agrawala P; Kraeling M; Sathyan G; Berger K
    J Pharm Sci; 1988 Sep; 77(9):757-9. PubMed ID: 3225769
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Absorption profile and absolute bioavailability of a theophylline--retard preparation].
    Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
    Arzneimittelforschung; 1990 Nov; 40(11):1218-24. PubMed ID: 2085333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sustained-release pellets of nifedipine using microcrystals combined with MCC-based matrix.
    Ma J; Wang J; Cheng Z; Yin T; Teng H; Xu H; Tang X; Cai C
    Drug Dev Ind Pharm; 2015 Feb; 41(2):307-14. PubMed ID: 24320880
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of polysaccharide gel-coated pellets for oral administration: swelling and release behavior of calcium pectinate gel.
    Sriamornsak P; Kennedy RA
    AAPS PharmSciTech; 2007 Sep; 8(3):E79. PubMed ID: 17915829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization and evaluation of self-nanoemulsifying sustained-release pellet formulation of ziprasidone with enhanced bioavailability and no food effect.
    Miao Y; Chen G; Ren L; Pingkai O
    Drug Deliv; 2016 Sep; 23(7):2163-2172. PubMed ID: 25148542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
    Liu Y; Sun Y; Sun J; Zhao N; Sun M; He Z
    Int J Pharm; 2012 Apr; 426(1-2):21-28. PubMed ID: 22266529
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation of sustained release hydrophilic matrices by melt granulation in a high-shear mixer.
    Ochoa L; Igartua M; Hernández RM; Gascón AR; Pedraz JL
    J Pharm Pharm Sci; 2005 Jun; 8(2):132-40. PubMed ID: 16124924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preparation and characterization and release properties of Eudragit RS based ibuprofen pellets prepared by extrusion spheronization: effect of binder type and concentration.
    Garekani HA; Nokhodchi A; Rayeni MA; Sadeghi F
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1238-46. PubMed ID: 22873946
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preparation and evaluation of ziprasidone-phospholipid complex from sustained-release pellet formulation with enhanced bioavailability and no food effect.
    Miao Y; Chen G; Ren L; Ouyang P
    J Pharm Pharmacol; 2016 Feb; 68(2):185-94. PubMed ID: 26748446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of partially hydrolysed polyvinyl alcohol for the production of high drug-loaded sustained release pellets via extrusion-spheronisation and coating: In vitro and in vivo evaluation.
    Verstraete G; De Jaeghere W; Vercruysse J; Grymonpré W; Vanhoorne V; Stauffer F; De Beer T; Bezuijen A; Remon JP; Vervaet C
    Int J Pharm; 2017 Jan; 517(1-2):88-95. PubMed ID: 27919698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C; Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of novel sustained release matrix pellets of betahistine dihydrochloride: effect of lipophilic surfactants and co-surfactants.
    Shamma RN; Basalious EB; Shoukri R
    Pharm Dev Technol; 2012; 17(5):583-93. PubMed ID: 21770719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determination of the release mechanism of Theophylline from pellets coated with Surelease
    Kazlauske J; Cafaro MM; Caccavo D; Marucci M; Lamberti G; Barba AA; Larsson A
    Int J Pharm; 2017 Aug; 528(1-2):345-353. PubMed ID: 28583332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Bioavailability of theophylline in a new oral sustained-release preparation (author's transl)].
    Schneider GF; Heese GU; Huber HJ; Janzen N; Jünger H; Moser C; Stanislaus F
    Arzneimittelforschung; 1981; 31(9):1489-97. PubMed ID: 7197962
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo/in vitro correlation of experimental sustained-release theophylline formulations.
    Yuen KH; Desmukh AA; Newton JM
    Pharm Res; 1993 Apr; 10(4):588-92. PubMed ID: 8483843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
    Bando H; McGinity JW
    Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.